ALK/HDAC-IN-1
ALK/HDAC-IN-1 is a dual inhibitor for ALK and HDAC6, with IC50s of 16 nM and 1.03 μM, respectively. ALK/HDAC-IN-1 exhibits antitumor activity.
For research use only. We do not sell to patients.
- Formula: C27H31N5O4
- Molecular Weight:489.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
HDAC6 1.03 μM (IC50) |
HDAC8 1.69 μM (IC50) |
HDAC1 10.8 μM (IC50) |
HDAC11 16.6 μM (IC50) |
ALK/HDAC-IN-1 inihibits proliferations of cancer cells A549, HepG2, MCF7, U87MG and H2228, with IC50s of 0.33, 0.59, 0.55, 0.62 and 0.44 μM, respectively[1].
ALK/HDAC-IN-1 inihibits CYP450 enzymes CYP2C9 with IC50 of 2.65 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549, HepG2, MCF7, U87MG and H2228
-
Concentration:
-
Incubation Time:48 h
-
Result:Inhibited proliferations with sub-micromolar level IC50 values.
-
Cell Line:H2228
-
Concentration:2 μM
-
Incubation Time:6 h
-
Result:Ptomoted acetylation of α-tubulin and histone H3.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 xenografted BALB/c mice[1]
-
Dosage:0-20 mg/kg
-
Administration:i.p., once daily for 21 days
-
Result:Decrease tumor growth with TGIs of 68% and 85%, with dose of 10 and 20 mg/kg, respectively.
Chemical Information
-
Molecular Weight 489.57
-
Formula C27H31N5O4
-
SMILES
O=C(/N=C1N([C@@H]2CC[C@H](C(NC(C)C)=O)CC2)C3=CC=C(/C=C/C(NO)=O)C=C3N/1)C4=CC=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)